Publications
2023
Di Cristo L., Sabella S.
Cell Cultures at the Air–Liquid Interface and Their Application in Cancer Research
Methods in molecular biology (Clifton, N.J.), vol. 2645, pp. 41-64
Book Chapter
Book Series
2023
Di Cristo L., Keller J.G., Leoncino L., Marassi V., Loosli F., Seleci D.A., Tsiliki G., Oomen A.G., Stone V., Wohlleben W., Sabella S.
Critical aspects in dissolution testing of nanomaterials in the oro-gastrointestinal tract: the relevance of juice composition for hazard identification and grouping
Nanoscale Advances
2023
Demuro S., Di Martino R.M.C., Sauvey C., Tripathi S.K., Ortega J. A., Russo D., Penna I., Myers S. H., Bandiera T., Girotto S., Abagyan R., Cavalli A.
Design and synthesis of triple protein kinase inhibitors: paving the way towards novel CNS tools to reverse the aberrant tau phosphorylation
ACS Spring 2023 meeting
Poster
Conference
2023
Anselmi M., Bellina F., Quaia R., Panosetti M., Veronesi M., Girotto S., Bertozzi F., Duca M., Bandiera T.
DISCOVERY OF SMALL-MOLECULE INHIBITORS OF MICRORNA-21 BIOGENESIS
IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry
Poster
Conference
2023
Bellina F., Berti F., Bertozzi S.M., Bandiera T., Bertozzi F.
Highly diastereoselective Heck-Matsuda reaction with pyrazolyl diazonium salts
New Journal of Chemistry
2023
Veronesi M., Bertozzi F., Panosetti M., Bellina F., Quaia R., Anselmi M., Girotto S., Duca M., Bandiera T.
IDENTIFICATION OF BINDERS TO PRE-MIR-21 BY 19F-NMR FRAGMENT-BASED LEAD DISCOVERY
XXVIII National Meeting on Medicinal Chemistry
Poster
Conference
2023
Renda M., Barreca M., Borrelli A., Spanò V., Montalbano A., Raimondi M.V., Bivacqua R., Musante I., Scudieri P., Guidone D., Buccirossi M., Genovese M., Venturini A., Bandiera T., Barraja P., Galietta L.J.V.
Novel tricyclic pyrrolo‑quinolines as pharmacological correctors of the mutant CFTR chloride channel
Scientific Reports, vol. 13
2023
Genovese M., Guidone D., Buccirossi M., Borrelli A., Rodriguez Gimeno A., Bertozzi F., Bandiera T., Galietta L.J.V.
Pharmacological potentiators of the calcium signaling cascade identified by high-throughput screening
PNAS Nexus, vol. 2
2023
Romeo E., Saccoliti F., Laselva O., Falchi F., Liessi N., Pastorino C., Armirotti A., Girotto S., Pedemonte N., Bandiera T., Bertozzi F.
Photo-Affinity Labeling (PAL) as a suited approach to investigate the mechanism of action of CFTR corrector ARN23765
18th ECFS Basic Science Conference
Poster
Conference
2023
Tolardo V., Romaldini A., Fumagalli F., Armirotti A., Veronesi M., Magri D., Sabella S., Athanassiou A., Fragouli D.
Polycarbonate nanoplastics and the in vitro assessment of their toxicological impact on liver functionality
Environmental Science: Nano
2023
Tolardo V., Romaldini A., Fumagalli F., Armirotti A., Veronesi M., Magrì D., Sabella S., Athanassiou A., Fragouli D.
Polycarbonate nanoplastics and the in vitro assessment of their toxicological impact on liver functionality
Environmental Science: Nano
Article in Press
Journal
2023
Saccoliti F., Romeo E., Bertozzi F.
Reazioni bioortogonali: la chimica applicata ai sistemi viventi
La Chimica e l’Industria, (no. 1), pp. 54-60
Article
Journal
2023
Pismataro M.C., Astolfi A., Barreca M.L., Pacetti M., Schenone S., Bandiera T., Carbone A., Massari S.
Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy
Journal of Medicinal and Pharmaceutical Chemistry
2022
Cavallo D., Ursini C.L., Fresegna A.M., Ciervo A., Boccuni F., Ferrante R., Tombolini F., Maiello R., Chiarella P., Buresti G., Del Frate V., Poli D., Andreoli R., Di Cristo L., Sabella S., Iavicoli S.
A follow-up study on workers involved in the graphene production process after the introduction of exposure mitigation measures: evaluation of genotoxic and oxidative effects
Nanotoxicology, vol. 16, (no. 6-8), pp. 776-790
Article
Journal
2022
Demuro S., Sauvey C., Tripathi S.K., Di Martino R.M.C., Shi D., Ortega J.A., Russo D., Balboni B., Giabbai B., Storici P., Girotto S., Abagyan R., Cavalli A.
ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders
European Journal of Medicinal Chemistry, vol. 229